Heart Closure Devices Market Report 2026

Heart Closure Devices Market Overview

• Heart Closure Devices market size has reached to $3.08 billion in 2025 • Expected to grow to $5.42 billion in 2030 at a compound annual growth rate (CAGR) of 11.9% • Growth Driver: Growth Of Market Driven By Rising Congenital Heart Defects • Market Trend: AtriCure Launches Low-Profile Surgical LAA Devices To Advance Surgical Left Atrial Appendage Management • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Heart Closure Devices Market?

Heart closure devices are advanced medical tools designed to seal holes or openings in the heart, commonly arising from congenital defects or surgical interventions. They are used to treat conditions such as atrial septal defects (ASD), patent foramen ovale (PFO), and other structural heart abnormalities. These minimally invasive devices are typically delivered through catheter-based procedures, offering a safer alternative to open-heart surgery. The main products of heart closure devices are atrial septal defect (ASD) closure devices, ventricular septal defect (VSD) closure devices, patent foramen ovale (PFO) closure devices, left atrial appendage (LAA) closure devices, and other products. Atrial septal defect (ASD) closure devices are medical implants used to seal abnormal openings in the septum between the heart's upper chambers, typically deployed via minimally invasive catheter-based procedures. Materials used for this are nitinol-based devices, stainless steel devices, and other materials. Delivery methods encompass transcatheter delivery and surgical delivery, catering to various end users such as hospitals, ambulatory surgical centers (ASCs), cardiac catheterization laboratories, and others.

What Is The Heart Closure Devices Market Growth Forecast?

The heart closure devices market size is expected to see rapid growth in the next few years. It will grow to $5.42 billion in 2030 at a compound annual growth rate (CAGR) of 11.9%. The growth in the forecast period can be attributed to increasing demand for catheter-based cardiac therapies, rising investments in structural heart disease treatment, expansion of specialized cardiac centers, growing focus on reducing surgical risks, technological advancements in closure device design. Major trends in the forecast period include increasing adoption of transcatheter heart closure procedures, rising demand for minimally invasive cardiac devices, growing use of nitinol-based closure systems, expansion of structural heart intervention programs, enhanced focus on procedural safety and efficacy.

Global Heart Closure Devices Market Segmentation

1) By Product: Atrial Septal Defect (ASD) Closure Devices, Ventricular Septal Defect (VSD) Closure Devices, Patent Foramen Ovale (PFO) Closure Devices, Left Atrial Appendage (LAA) Closure Devices, Other Products 2) By Material: Nitinol-Based Devices, Stainless Steel Devices, Other Materials 3) By Mode of Delivery: Transcatheter Delivery, Surgical Delivery 4) By End Use: Hospitals, Ambulatory Surgical Centers (ASCs), Cardiac Catheterization Laboratories, Other End Uses Subsegments: 1) By Atrial Septal Defect (ASD) Closure Devices: Self-expanding Occluders, Balloon-expandable Occluders, Other ASD Closure Devices 2) By Ventricular Septal Defect (VSD) Closure Devices: Transcatheter VSD Closure Devices, Surgical VSD Closure Devices, Other VSD Closure Devices 3) By Patent Foramen Ovale (PFO) Closure Devices: Double-Disc Occluders, Single-Disc Occluders, Other PFO Closure Devices 4) By Left Atrial Appendage (LAA) Closure Devices: LAA Occluders, LAA Clip Systems, Other LAA Closure Devices 5) By Other Products: Septal Defect Closure Devices, Endovascular Closure Devices, Other Specialty Closure Devices

What Is The Driver Of The Heart Closure Devices Market?

The increasing incidence of cardiovascular diseases (CVDs) is expected to propel the growth of the heart closure devices market going forward. The increasing incidence of cardiovascular diseases (CVDs) is driven by factors such as aging, unhealthy lifestyle choices, genetic predisposition, and increasing prevalence of risk factors such as hypertension, diabetes, and obesity. Heart closure devices help reduce the incidence of complications from congenital heart defects by minimally invasively closing abnormal openings in the heart, improving blood flow, and preventing further health issues. For instance, in May 2024, according to the Singapore Heart Foundation (SHF), a Singapore-based non-profit organization, the total number of deaths from cardiovascular disease accounted for 26,885 in 2023. Moreover, ischemic heart disease resulted in 5,302 deaths, showing an increase from 5,290 deaths in 2022. Therefore, the increasing incidence of cardiovascular diseases (CVDs) is driving the growth of the heart closure devices industry.

Key Players In The Global Heart Closure Devices Market

Major companies operating in the heart closure devices market are Abbott Laboratories, Medtronic plc, Boston Scientific Corp., Lepu Medical Technology Ltd., Terumo Corporation, Edwards Lifesciences, Teleflex Incorporated, Merit Medical Systems Inc., Cordis Corporation, AtriCure Inc., Lifetech Scientific Corp., Sahajanand Medical Technologies, W. L. Gore And Associates Inc., Occlutech GmbH, NMT Medical Inc., Sorin Group Italia S.p.A., Vivasure Medical Limited, B Braun Interventional Systems, HeartStitch Inc., MicroPort Scientific Corporation

Global Heart Closure Devices Market Trends and Insights

Major companies operating in the heart closure devices market are focusing on technological innovation, such as low-profile, ergonomic surgical LAA devices with continuous closing force mechanisms, to enhance procedural precision, visibility, and ease of use for physicians while improving patient outcomes. Low-Profile Surgical LAA Devices enable safe and effective closure of the left atrial appendage, providing optimal tissue compression, simplified single-handed placement, and enhanced access in minimally invasive procedures.For instance, in August 2024, AtriCure, Inc., a US-based cardiac surgical solutions company, launched first patient with its AtriClip FLEX-Mini device, the smallest-profile surgical LAA device on the market. Building on the proven AtriClip platform, the device features a fully enclosed design with parallel beams for continuous closing force, improved visibility, and an ergonomic handle for single-handed placement, supporting physicians in delivering precise, safe, and efficient LAA management for atrial fibrillation patients.

What Are Latest Mergers And Acquisitions In The Heart Closure Devices Market?

In November 2023, Johnson & Johnson MedTech, a US-based company that develops medical devices and treatments, acquired Laminar Inc. for $400 million. With this acquisition, Johnson & Johnson MedTech aims to enhance its product portfolio in cardiac arrhythmia treatment, deepen its market presence in left atrial appendage elimination devices, and innovate solutions for stroke prevention in patients with non-valvular atrial fibrillation. Laminar Inc. is a US-based medical equipment manufacturer company that develops heart closure devices.

Regional Outlook

North America was the largest region in the heart closure devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Heart Closure Devices Market?

The heart closure devices market consists of sales of septal occluders, embolic protection devices, valvular closure devices, balloon occlusion devices, and transcatheter closure devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.